WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+0.44%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.04B
AUM Growth
+$681M
(+13%)
Cap. Flow
+$769M
Cap. Flow
% of AUM
12.72%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
793
New
206
Increased
110
Reduced
107
Closed
121
Top Buys
| 1 |
Qualcomm
QCOM
|
+$77.3M |
| 2 |
Abbott
ABT
|
+$69.2M |
| 3 |
Legend Biotech
LEGN
|
+$61M |
| 4 |
NVIDIA
NVDA
|
+$60.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$47.1M |
Top Sells
| 1 |
Amphenol
APH
|
+$98.4M |
| 2 |
Texas Instruments
TXN
|
+$96.2M |
| 3 |
Global Payments
GPN
|
+$49.2M |
| 4 |
KLA
KLAC
|
+$49.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$46.8M |
Sector Composition
| 1 | Healthcare | 46.87% |
| 2 | Technology | 26.26% |
| 3 | Communication Services | 9.09% |
| 4 | Financials | 5.54% |
| 5 | Consumer Staples | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
System1
SST
$62.9M
| $7.43M | 0.12% |
+75,000
| New | +$7.43M |
|
202
Keros Therapeutics
KROS
$630M
| $7.43M | 0.12% |
+187,835
| New | +$7.43M |
|
|
GCAC
203
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $7.41M | 0.12% |
+750,000
| New | +$7.41M |
|
|
RACB
204
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $7.39M | 0.12% |
750,000
| – | – |
|
|
NARI
205
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $7.34M | 0.12% |
+90,438
| New | +$7.34M |
|
206
Freshpet
FRPT
$2.73B
| $7.29M | 0.12% |
51,095
+4,244
| +9% | +$606K |
|
207
Tenet Healthcare
THC
$17.1B
| $7.22M | 0.12% |
108,628
-57,362
| -35% | -$3.81M |
|
|
MAAC
208
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| $7.19M | 0.12% |
+718,963
| New | +$7.19M |
|
209
Perrigo
PRGO
$3.05B
| $7.18M | 0.12% |
151,639
| – | – |
|
210
Zai Lab
ZLAB
$3.48B
| $7.03M | 0.11% |
66,660
-18,399
| -22% | -$1.94M |
|
211
Acumen Pharmaceuticals
ABOS
$84.8M
| $6.97M | 0.11% |
+468,794
| New | +$6.97M |
|
|
CLYM
212
Climb Bio, Inc. Common Stock
CLYM
$163M
| $6.96M | 0.11% |
+387,224
| New | +$6.96M |
|
|
HLGN
213
DELISTED
Heliogen, Inc.
HLGN
| $6.91M | 0.11% |
19,901
+10,615
| +114% | +$3.69M |
|
214
Invivyd
IVVD
$241M
| $6.82M | 0.11% |
+161,459
| New | +$6.82M |
|
215
Akebia Therapeutics
AKBA
$814M
| $6.69M | 0.11% |
2,323,517
+2,199,743
| +1,777% | +$6.34M |
|
216
Encompass Health
EHC
$12.5B
| $6.61M | 0.11% |
110,762
+23,483
| +27% | +$1.4M |
|
217
Centene
CNC
$14.7B
| $6.57M | 0.11% |
105,420
-49,597
| -32% | -$3.09M |
|
218
Atea Pharmaceuticals
AVIR
$255M
| $6.5M | 0.11% |
185,265
-2,540
| -1% | -$89K |
|
219
Janux Therapeutics
JANX
$1.47B
| $6.49M | 0.11% |
300,031
-34,229
| -10% | -$740K |
|
|
ZGNX
220
DELISTED
Zogenix, Inc.
ZGNX
| $6.47M | 0.11% |
426,140
-315,419
| -43% | -$4.79M |
|
221
Tango Therapeutics
TNGX
$765M
| $6.47M | 0.11% |
500,040
-3,357
| -0.7% | -$43.4K |
|
222
Tyra Biosciences
TYRA
$632M
| $6.44M | 0.11% |
+366,035
| New | +$6.44M |
|
223
Century Therapeutics
IPSC
$43.6M
| $6.29M | 0.1% |
250,094
-31,632
| -11% | -$796K |
|
|
ATH
224
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $6.26M | 0.1% |
+90,860
| New | +$6.26M |
|
225
SentinelOne
S
$6.01B
| $6.25M | 0.1% |
116,668
| – | – |
|